Alaunos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
CEOHolger Weis
CEOHolger Weis
Employees1
Employees1
HeadquartersFort Lauderdale, Florida
HeadquartersFort Lauderdale, Florida
Founded2003
Founded2003
Employees1
Employees1
TCRT Key Statistics
Market cap7.43M
Market cap7.43M
Price-Earnings ratio-1.45
Price-Earnings ratio-1.45
Dividend yield—
Dividend yield—
Average volume72.20K
Average volume72.20K
High today$3.67
High today$3.67
Low today$3.04
Low today$3.04
Open price$3.15
Open price$3.15
Volume64.58K
Volume64.58K
52 Week high$6.20
52 Week high$6.20
52 Week low$1.31
52 Week low$1.31
Stock Snapshot
As of today, Alaunos Therapeutics(TCRT) shares are valued at $3.50. The company's market cap stands at 7.43M, with a P/E ratio of -1.45.
During the trading session on 2025-11-25, Alaunos Therapeutics(TCRT) shares reached a daily high of $3.67 and a low of $3.04. At a current price of $3.50, the stock is +15.1% higher than the low and still -4.6% under the high.
Trading activity shows a volume of 64.58K, compared to an average daily volume of 72.2K.
Over the past 52 weeks, Alaunos Therapeutics(TCRT) stock has traded between a high of $6.20 and a low of $1.31.
Over the past 52 weeks, Alaunos Therapeutics(TCRT) stock has traded between a high of $6.20 and a low of $1.31.
People also own
Based on the portfolios of people who own TCRT. This list is generated using Robinhood data, and it’s not a recommendation.